| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO
1 company
Kenneth Allen Myszkowski last filed a Form 4 in January 2025, as Chief Financial Officer at ARWR. From March 2015 to January 2025, the filings on record show 0 open-market purchases and 23 sales. Kenneth Allen Myszkowski's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Kenneth Allen Myszkowski's trades have earned a middling insider score of 68/100 across 7 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of -2.3%.
At the last filing, the largest reported position was 455,433 shares of ARWR. The ARWR filings lean toward selling, a net 669,053 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 40,313 | $49.44 | $1,992,924.63 | -9.5% | |
| Jan 6, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 20,000 | $60.11 | $1,202,200.60 | -4.9% | |
| Nov 1, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 37,884 | $40.85 | $1,547,378.04 | -10.8% | |
| May 21, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 27,071 | $22.00 | $595,562.00 | -8.9% | |
| Feb 19, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 8,000 | $18.00 | $144,000.00 | -2.6% | |
| Jan 17, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 81,875 | $14.55 | $1,191,281.25 | -21.1% | |
| Jan 2, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 8,333 | $11.98 | $99,829.34 | -2.1% | |
| Sep 6, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 45,000 | $19.34 | $870,200.00 | -12.6% | |
| Jun 19, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 20,000 | $14.01 | $280,200.00 | -6.0% | |
| May 31, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 14,000 | $11.00 | $154,000.00 | -4.3% |